These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 15689575)

  • 21. Effect of puberty on body composition.
    Loomba-Albrecht LA; Styne DM
    Curr Opin Endocrinol Diabetes Obes; 2009 Feb; 16(1):10-5. PubMed ID: 19115520
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Insulin-like growth factor-I as a reflection of body composition, nutrition, and puberty in sixth and seventh grade girls.
    Wilson DM; Killen JD; Hammer LD; Litt IF; Vosti C; Miner B; Hayward C; Taylor CB
    J Clin Endocrinol Metab; 1991 Oct; 73(4):907-12. PubMed ID: 1890162
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Alterations in body composition and fat distribution in growth hormone-deficient prepubertal children during growth hormone therapy.
    Roemmich JN; Huerta MG; Sundaresan SM; Rogol AD
    Metabolism; 2001 May; 50(5):537-47. PubMed ID: 11319714
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum levels of insulin-like growth factor (IGF)-binding protein-3 (IGFBP-3) in healthy infants, children, and adolescents: the relation to IGF-I, IGF-II, IGFBP-1, IGFBP-2, age, sex, body mass index, and pubertal maturation.
    Juul A; Dalgaard P; Blum WF; Bang P; Hall K; Michaelsen KF; Müller J; Skakkebaek NE
    J Clin Endocrinol Metab; 1995 Aug; 80(8):2534-42. PubMed ID: 7543116
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of puberty on the relationship between circulating leptin and body composition.
    Horlick MB; Rosenbaum M; Nicolson M; Levine LS; Fedun B; Wang J; Pierson RN; Leibel RL
    J Clin Endocrinol Metab; 2000 Jul; 85(7):2509-18. PubMed ID: 10902802
    [TBL] [Abstract][Full Text] [Related]  

  • 26. GH therapy in transition age: state of the art and future perspectives.
    Cappa M; Caruso M; Saggese G; Salerno MC; Tonini G
    Minerva Endocrinol; 2015 Mar; 40(1):23-35. PubMed ID: 25660320
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association of lean and fat body mass, bone biomarkers and gonadal steroids with bone mass during pre- and midpuberty.
    Csakvary V; Erhardt E; Vargha P; Oroszlan G; Bodecs T; Torok D; Toldy E; Kovacs GL
    Horm Res Paediatr; 2012; 78(4):203-11. PubMed ID: 23147421
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bone mineral density and body composition before and during treatment with gonadotropin-releasing hormone agonist in children with central precocious and early puberty.
    Boot AM; De Muinck Keizer-Schrama S; Pols HA; Krenning EP; Drop SL
    J Clin Endocrinol Metab; 1998 Feb; 83(2):370-3. PubMed ID: 9467543
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Testosterone deficiency in young men: marked alterations in whole body protein kinetics, strength, and adiposity.
    Mauras N; Hayes V; Welch S; Rini A; Helgeson K; Dokler M; Veldhuis JD; Urban RJ
    J Clin Endocrinol Metab; 1998 Jun; 83(6):1886-92. PubMed ID: 9626114
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The relation between bone mineral density, insulin-like growth factor I, lipoprotein (a), body composition, and muscle strength in adolescent males.
    Thorsen K; Nordström P; Lorentzon R; Dahlén GH
    J Clin Endocrinol Metab; 1999 Sep; 84(9):3025-9. PubMed ID: 10487659
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High dose recombinant human growth hormone (GH) treatment of GH-deficient patients in puberty increases near-final height: a randomized, multicenter trial. Genentech, Inc., Cooperative Study Group.
    Mauras N; Attie KM; Reiter EO; Saenger P; Baptista J
    J Clin Endocrinol Metab; 2000 Oct; 85(10):3653-60. PubMed ID: 11061518
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Estrogen and testosterone, but not a nonaromatizable androgen, direct network integration of the hypothalamo-somatotrope (growth hormone)-insulin-like growth factor I axis in the human: evidence from pubertal pathophysiology and sex-steroid hormone replacement.
    Veldhuis JD; Metzger DL; Martha PM; Mauras N; Kerrigan JR; Keenan B; Rogol AD; Pincus SM
    J Clin Endocrinol Metab; 1997 Oct; 82(10):3414-20. PubMed ID: 9329378
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bone turnover markers during pubertal development: relationships with growth factors and adipocytokines.
    Jürimäe J; Mäestu J; Jürimäe T
    Med Sport Sci; 2010; 55():114-127. PubMed ID: 20956864
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Baseline characteristics and the effects of five years of GH replacement therapy in adults with GH deficiency of childhood or adulthood onset: a comparative, prospective study.
    Koranyi J; Svensson J; Götherström G; Sunnerhagen KS; Bengtsson B; Johannsson G
    J Clin Endocrinol Metab; 2001 Oct; 86(10):4693-9. PubMed ID: 11600527
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Whole body BMC in pediatric Crohn disease: independent effects of altered growth, maturation, and body composition.
    Burnham JM; Shults J; Semeao E; Foster B; Zemel BS; Stallings VA; Leonard MB
    J Bone Miner Res; 2004 Dec; 19(12):1961-8. PubMed ID: 15537438
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bone mineral density in children and adolescents with Prader-Willi syndrome: a longitudinal study during puberty and 9 years of growth hormone treatment.
    Bakker NE; Kuppens RJ; Siemensma EP; Tummers-de Lind van Wijngaarden RF; Festen DA; Bindels-de Heus GC; Bocca G; Haring DA; Hoorweg-Nijman JJ; Houdijk EC; Jira PE; Lunshof L; Odink RJ; Oostdijk W; Rotteveel J; Van Alfen AA; Van Leeuwen M; Van Wieringen H; Wegdam-den Boer ME; Zwaveling-Soonawala N; Hokken-Koelega AC
    J Clin Endocrinol Metab; 2015 Apr; 100(4):1609-18. PubMed ID: 25668198
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bone mineral density and body composition in short children born SGA during growth hormone and gonadotropin releasing hormone analog treatment.
    Lem AJ; van der Kaay DC; Hokken-Koelega AC
    J Clin Endocrinol Metab; 2013 Jan; 98(1):77-86. PubMed ID: 23125290
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Growth hormone-dependent insulin-like growth factor binding protein is a major determinant of bone mineral density in healthy men.
    Johansson AG; Forslund A; Hambraeus L; Blum WF; Ljunghall S
    J Bone Miner Res; 1994 Jun; 9(6):915-21. PubMed ID: 7521562
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term effects of growth hormone (GH) treatment on body composition and bone mineral density in short children born small-for-gestational-age: six-year follow-up of a randomized controlled GH trial.
    Willemsen RH; Arends NJ; Bakker-van Waarde WM; Jansen M; van Mil EG; Mulder J; Odink RJ; Reeser M; Rongen-Westerlaken C; Stokvis-Brantsma WH; Waelkens JJ; Hokken-Koelega AC
    Clin Endocrinol (Oxf); 2007 Oct; 67(4):485-92. PubMed ID: 17561977
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relationship between the growth hormone/insulin-like growth factor-I axis, insulin sensitivity, and adrenal androgens in normal prepubertal and pubertal girls.
    Guercio G; Rivarola MA; Chaler E; Maceiras M; Belgorosky A
    J Clin Endocrinol Metab; 2003 Mar; 88(3):1389-93. PubMed ID: 12629134
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.